Virus nanoparticle intratumoral vaccines for HER2+ malignancies
Our laboratory specializes in the intratumoral (i.t.) delivery of virus nanoparticles (VNPs) that activate immune cells and modulate the tumor microenvironment (TME). For this study, we conjugated the CH401 peptide—containing B–cell, helper T-cell, and cytotoxic T–cell epitopes of HER2—to the plant...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2025-12-01
|
| Sarja: | OncoImmunology |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/2162402X.2025.2583553 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|